NYSE:CIVI

Stock Analysis Report

Executive Summary

Civitas Solutions, Inc. provides home- and community-based health and human services to must-serve individuals with intellectual, developmental, behavioral, and/or medically complex challenges in the United States.

Snowflake

Fundamentals

Moderate growth potential with questionable track record.


Similar Companies

Share Price & News

How has Civitas Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

CIVI

4.6%

US Healthcare

2.3%

US Market


1 Year Return

22.9%

CIVI

-8.5%

US Healthcare

5.6%

US Market


Shareholder returns

CIVIIndustryMarket
7 Day0%4.6%2.3%
30 Day0.3%-0.1%-1.0%
90 Day30.1%-4.5%-0.7%
1 Year22.9%22.9%-7.1%-8.5%7.9%5.6%
3 Year-1.9%-1.9%31.9%26.5%45.6%36.3%
5 Yearn/a63.7%53.9%65.8%47.6%

Price Volatility Vs. Market

How volatile is Civitas Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Civitas Solutions undervalued compared to its fair value and its price relative to the market?

7.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued:

Significantly Undervalued: CIVI is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: CIVI is poor value based on its PE Ratio (54.5x) compared to the Healthcare industry average (20.3x).

PE vs Market: CIVI is poor value based on its PE Ratio (54.5x) compared to the US market (17.7x).


Price to Earnings Growth Ratio

Low PEG Ratio: CIVI is poor value based on its PEG Ratio (1.1x)


Price to Book Ratio

PB vs Industry: CIVI is overvalued based on its PB Ratio (3.7x) compared to the US Healthcare industry average (2.5x).


Next Steps

Future Growth

How is Civitas Solutions forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

49.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CIVI's forecast earnings growth (49% per year) is above the savings rate (2.7%).

Earnings vs Market: CIVI's earnings (49% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CIVI's revenue (4.8% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: CIVI's revenue (4.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Civitas Solutions performed over the past 5 years?

59.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CIVI has become profitable over the past 5 years, growing earnings by 59.7% per year.

Accelerating Growth: CIVI's earnings growth over the past year (2.9%) is below its 5-year average (59.7% per year).

Earnings vs Industry: CIVI earnings growth over the past year (2.9%) underperformed the Healthcare industry 5.3%.


Return on Equity

High ROE: CIVI's Return on Equity (6.9%) is considered low.


Return on Assets

ROA vs Industry: CIVI's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: CIVI has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Civitas Solutions's financial position?


Financial Position Analysis

Short Term Liabilities: CIVI's short term assets ($199.7M) exceeds its short term liabilities ($144.4M)

Long Term Liabilities: CIVI's short term assets (199.7M) do not cover its long term liabilities (782.3M)


Debt to Equity History and Analysis

Debt Level: CIVI's debt to equity ratio (408.2%) is considered high

Reducing Debt: CIVI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Debt Coverage: CIVI's debt is not well covered by operating cash flow (16.1%).

Interest Coverage: CIVI's interest payments on its debt are not well covered by EBIT (2.1x coverage).


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Civitas Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.6%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate CIVI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CIVI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CIVI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CIVI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of Civitas Solutions's salary, the management and board of directors tenure and is there insider trading?

4.7yrs

Average management tenure


CEO

Bruce Nardella (61yo)

5.2yrs

Tenure

US$2,755,872

Compensation

Mr. Bruce F. Nardella has been the Chief Executive Officer and President of Civitas Solutions, Inc. since January 1, 2014 and December 2009 respectively. He is responsible for ensuring the Civitas’ leaders ...


CEO Compensation Analysis

Information is not available.

Compensation vs Earnings: Bruce's compensation has been consistent with company performance over the past year.


Management Age and Tenure

4.7yrs

Average Tenure

51yo

Average Age

Experienced Management: CIVI's management team is considered experienced (4.7 years average tenure).


Board Age and Tenure

3.5yrs

Average Tenure

62yo

Average Age

Experienced Board: CIVI's board of directors are considered experienced (3.5 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$2,204,65111 Mar 19
GAMCO Investors, Inc.
EntityCompany
Shares124,600
Max PriceUS$17.72
BuyUS$7,07211 Mar 19
Gabelli & Company Investment Advisers, Inc.
EntityCompany
Shares400
Max PriceUS$17.68
SellUS$452,54011 Mar 19
GAMCO Investors, Inc.
EntityCompany
Shares25,500
Max PriceUS$17.87
SellUS$523,88011 Mar 19
Gabelli & Company Investment Advisers, Inc.
EntityCompany
Shares29,500
Max PriceUS$17.87
SellUS$31,204,44711 Mar 19
GAMCO Investors, Inc.
EntityCompany
Shares1,757,997
Max PriceUS$17.75
SellUS$5,190,98811 Mar 19
Gabelli & Company Investment Advisers, Inc.
EntityCompany
Shares292,450
Max PriceUS$17.75
BuyUS$5,660,88804 Feb 19
Gabelli & Company Investment Advisers, Inc.
EntityCompany
Shares321,550
Max PriceUS$17.61
BuyUS$29,359,42604 Feb 19
GAMCO Investors, Inc.
EntityCompany
Shares1,658,897
Max PriceUS$17.72

Ownership Breakdown


Management Team

  • Dwight Robson (47yo)

    Chief Public Strategy & Marketing Officer

    • Tenure: 8yrs
  • Bruce Nardella (61yo)

    Chairman

    • Tenure: 5.2yrs
    • Compensation: US$2.76m
  • Denis Holler (64yo)

    Chief Financial Officer

    • Tenure: 11.8yrs
    • Compensation: US$955.90k
  • Brett Cohen (45yo)

    Chief Operating Officer

    • Tenure: 3.3yrs
    • Compensation: US$1.12m
  • Jeffrey Cohen (50yo)

    Chief Information Officer

    • Tenure: 7.3yrs
    • Compensation: US$646.61k
  • Gerry Morrissey (65yo)

    Chief Quality Officer

    • Tenure: 4.7yrs
  • Bill Duffy

    President of Specialty Rehabilitation Services

    • Tenure: 2.1yrs
  • Maria McGee (52yo)

    Chief Human Resources Officer

    • Tenure: 1yrs
  • Gina Martin (47yo)

    Chief Legal Officer

    • Tenure: 1.2yrs

Board Members

  • Jim Elrod (62yo)

    Director

    • Tenure: 12.8yrs
  • Rob Rosner (58yo)

    Independent Director

    • Tenure: 0.6yrs
  • Pam Lenehan (66yo)

    Presiding Director

    • Tenure: 3.2yrs
    • Compensation: US$207.50k
  • Mary Tocio (70yo)

    Independent Director

    • Tenure: 3.4yrs
    • Compensation: US$199.58k
  • Greg Roth (62yo)

    Independent Director

    • Tenure: 3.5yrs
    • Compensation: US$205.00k
  • Guy Sansone (54yo)

    Director

    • Tenure: 9.3yrs
    • Compensation: US$202.50k
  • Bruce Nardella (61yo)

    Chairman

    • Tenure: 5.2yrs
    • Compensation: US$2.76m
  • Chris Durbin (53yo)

    Director

    • Tenure: 8.3yrs
  • Patrick Gray (69yo)

    Director

    • Tenure: 4.5yrs
    • Compensation: US$217.50k

Company Information

Civitas Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Civitas Solutions, Inc.
  • Ticker: CIVI
  • Exchange: NYSE
  • Founded: 1980
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$644.812m
  • Shares outstanding: 36.31m
  • Website: https://civitas-solutions.com

Number of Employees


Location

  • Civitas Solutions, Inc.
  • 313 Congress Street
  • 6th Floor
  • Boston
  • Massachusetts
  • 2210
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CIVINYSE (New York Stock Exchange)YesCommon StockUSUSDSep 2014
1CIDB (Deutsche Boerse AG)YesCommon StockDEEURSep 2014

Biography

Civitas Solutions, Inc. provides home- and community-based health and human services to must-serve individuals with intellectual, developmental, behavioral, and/or medically complex challenges in the Unite ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/03/09 00:53
End of Day Share Price2019/03/07 00:00
Earnings2018/12/31
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.